Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.
Pitot HC, McElroy EA Jr, Reid JM, Windebank AJ, Sloan JA, Erlichman C, Bagniewski PG, Walker DL, Rubin J, Goldberg RM, Adjei AA, Ames MM.
Pitot HC, et al. Among authors: rubin j.
Clin Cancer Res. 1999 Mar;5(3):525-31.
Clin Cancer Res. 1999.
PMID: 10100703
Clinical Trial.